Alx Oncology Holdings (ALXO) Total Debt (2019 - 2026)

Alx Oncology Holdings' Total Debt history runs 8 years deep, the most recent figure standing at $8.5 million for Q1 2026.

• In Q1 2026, Total Debt fell 14.63% year-over-year to $8.5 million; the TTM figure through Mar 2026 stood at $8.5 million (down 14.63% YoY), while the FY2025 annual figure was $9.7 million, down 1.57% from the prior year.
• Total Debt came in at $8.5 million for Q1 2026 at Alx Oncology Holdings, down from $9.7 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $11.0 million in Q4 2022 to a low of $5.0 million in Q2 2022.
• A 5-year average of $9.2 million and a median of $9.8 million in 2024 frame the typical range for Total Debt.
• Across the five-year window, Total Debt jumped 264.32% in 2022 and decreased 14.63% in 2026, its largest moves.
• Alx Oncology Holdings' Total Debt stood at $11.0 million in 2022, then dropped by 12.68% to $9.6 million in 2023, then climbed by 2.75% to $9.9 million in 2024, then fell by 1.57% to $9.7 million in 2025, then declined by 12.69% to $8.5 million in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $8.5 million, $9.7 million, and $10.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison